The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
If you see your cardiologist and they throw out the term “heart failure,” your heart might figuratively skip a beat. The ...
A systematic review and meta-analysis explored the relationship between androgen deprivation therapy and risk for heart failure in men with prostate cancer who were treated with ADT.
Medpage Today on MSN1d
No Clear Winner in SGLT2 Showdown for Cardiovascular Disease"These findings reinforce the use of dapagliflozin, 10 mg, or other SGLT2 inhibitors when the therapeutic goal is to reduce ...
The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...
A study by the Department of Veterans Affairs says that drugs like Ozempic can do plenty more than just help with weight loss ...
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback